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SUMMARY 
A new continuous-flow automated enzymatic method suitable for the direct deter- 
mination of creatinine in physiological samples is described. The proposed system utilizes 
an on-line gas predialysis unit in conjunction with a flow-through enzyme reactor coil 
and a potentiometric ammonia detector. The enzyme reactor contains immobilized 
creatinine iminohydrolase (EC 3.5.4.21) which converts creatinine to ammonia and 
N-methylhydantoin. Ammonia liberated from this reaction is detected downstream 
with the membrane electrode-based detector. The novel gas predialysis unit effectively 
removes >99.8% of endogenous ammonia (up to 1 mM) present in the sample. Thus, 
final peak potentials recorded by the electrode detector are directly proportional to the 
logarithm of creatinine concentrations present. The method is shown to be precise (< 3%), 
selective, and capable of accurately determining creatinine in serum and urine samples 
containing abnormally high endogenous ammonia levels. Determinations of creatinine in 
serum samples (n = 30) using this new method correlate well with an existing Technicon 
AutoAnalyzer calorimetric method (r = 0.996). 
In recent years, various selective enzymes have been coupled with ammo- 
nia detection methods to measure important amino acids and metabolites 
in physiological samples [l--6] . In such assays, ammonia liberated from 
the enzymatic reaction should be directly proportional to the concentration 
of analyte initially present in the sample. In reality, problems arise from the 
background levels of ammonia nitrogen (NH,-N) found in many biological 
samples. Indeed, normal blood ammonia levels are generally in the same 
concentration range as most amino acids and metabolites (10-100 pmol 
1-l) [7, 81. Moreover, any delay in analysis of the blood sample will result in 
large increases in background ammonia levels because of hydrolysis of labile 
glutamine and aspargine residues in proteins [9] . The problem is further 
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compounded when samples are drawn from patients with disease states that 
result in hyperammonemia (e.g., hepatic coma, Ryes syndrome, etc.), where 
ammonia can reach levels as high as 1 mmol 1-l in fresh serum [lo] . 
Various methods have been proposed to alleviate or correct for the endog- 
enous ammonia problem in blood and particularly urine. Time-consuming 
manual pretreatment steps including cation-exchange [ll, 121 and distil- 
lation [l3, 141 have been used. Difference measurements in which back- 
ground ammonia is first determined and then subtracted from the total 
ammonia present after the enzyme reaction have been proposed for blood 
analysis [ 111. Unfortunately, the accuracy of this latter method decreases 
when the ratio of endogenous ammonia to analyte levels increases. Recently, 
several researchers [2, 15-171 have used glutamate dehydrogenase (GLDH) 
to remove endogenous ammonia enzymatically 
NH: + cr-ketoglutarate + NADH + NAD+ + L-glutamate + Hz0 
from physiological samples. The method requires the use of NADH or 
NADPH, and soluble or immobilized GLDH, making the system less attract- 
ive for adaptation to high throughput autoanalyzer-type systems. In order to 
reduce the cost, the amount of NADH used per assay can be lowered; how- 
ever, this severely limits the concentration of endogenous ammonia which 
can be tolerated [lo] . 
In 1983, a novel flow-through on-line gas predialyzer was introduced, 
which was capable of removing approximately 90% of endogenous ammonia 
in serum and plasma samples [ 181. The original concept was demonstrated 
in an automated system for the determination of asparagine in plasma 
samp!es. While such a system could adequately reduce normal background 
ammonia levels, errors greater than 10% could still occur if samples con- 
tained abnormally high ammonia concentrations. In this paper, a simple 
temperature modification to the original on-line gas predialyzer design is 
described; it enables greater than 99.8% of the ammonia to be removed from 
serum and urine samples containing up to 1 mM ammonia. Additionally, 
this predialyzer is used in conjunction with immobilized creatinine imino- 
hydrolase enzyme (EC 3.5.4.21) to develop an automated system for the 
direct determination of creatinine in serum and urine samples. 
Creatinine levels in blood and urine are the most widely accepted indi- 
cators of kidney function. The classical Jaffe calorimetric method is known 
to suffer many interferences [ 191. Consequently, the accuracy and precision 
requirements of clinical creatinine assays require the development of non JaffC 
methods [ 201. Among alternative techniques it is well recognized that 
enzymatic methods can greatly enhance the selectivity of creatinine deter- 
minations [ 19, 211. Towards this end, the new system (Fig. 1) contains a 
tubular enzyme reactor coil to convert creatinine to N-methylhydantoin 
and ammonia. The ammonia is detected downstream with an improved 
membrane electrode-based detector [22] . The on-line predialyzer is placed 






Fig. 1. Flow diagram of automated creatinine system: (MC) mixing coil; (TC) on-line 
teflon predialyzer coil; (AR) acid reservoir trap; (ER) enzyme reactor coil, (DB) 
debubbler; (PS) pulse suppressor, (DC) gas dialysis chamber; (M) porous gas permeable 
membrane; (W) waste. Numbers represent flow-rates in ml min-’ . 
sample before it enters the enzyme coil. Consequently, detected ammonia 
is directly proportional to the concentration of creatinine, regardless of 
the initial ammonia level present in the sample. 
EXPERIMENTAL 
Apparatus 
A schematic diagram of the automated creatinine system is shown in 
Fig. 1. A Rainin (Woburn, MA) peristaltic pump was used to deliver the 
sample, reagents and air through the system. A Technicon Sampler II served 
as the autosampler, and was operated at a throughput of 30 samples per 
hour, with a 112 sample/wash ratio. 
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The ammonia predialysis unit consisted of a 4.2-m length of teflon gas- 
permeable tubing [poly(tetrafluoroethylene), l-mm i.d., 50% porosity, 
Anspec Company, Ann Arbor, MI] . The tubing was coiled and placed in a 
250-ml acid reservoir (0.2 mol l-l, pH 2.2, H3P04, NaOH buffer). The 
predialyzer was thermostated at temperatures ranging from 25 to 45”C, 
with optimal ammonia removal being obtained at 45°C. The predialyzer was 
preceded by a 40-s (1.5 ml) mixing coil that was also thermostated at the 
predialyzer temperature. The sample residence time in the predialysis coil 
was 110 s. 
The enzyme-reactor coil consisted of creatinine iminohydrolase immobil- 
ized on the inner walls of a l-m length of l.O-mm i.d. nylon tubing. The 
enzyme was obtained from G.D.S. Technology (Elkhart, IN) and was 
immobilized by established procedures [ 231. The specific activity of this 
enzyme coil was evaluated by the method described by Hornby and Noy 
[24] . The method was applied in the range 3-85 mmol 1-l creatinine where 
the fractional conversion varied, i.e., where the enzyme activity was rate- 
limiting. The apparent Michaelis-Menten constant, K’, was found to be 
2.8 X lo-’ mol 1-l. The specific activity of the enzyme coil was 0.84 pmol 
min-’ cm-‘. When stored as described below (see Reagents) the activity of 
this enzyme coil remained essentially constant for 1 year and several 
thousand creatinine samples. 
For certain preliminary experiments, commercial enzyme-reactor coils 
obtained from Farmitalia Carlo Erba (Milan, Italy) were used. The various 
enzyme reactors were thermostated at 37°C and preceded by a 25-s (1.5 ml) 
mixing coil maintained at the same temperature. Sample residence times in 
the enzyme reactor were usually lo-12 s. 
The potentiometric ammonia detection system used in this work was 
similar in design to those described previously [22, 251. An improvement 
in response to low levels of ammonia was achieved by using a custom- 
designed gas dialysis chamber (for details, see [26] ) which enhances the 
efficiency of gas transfer between the sample and recipient streams. The 
final configuration was further modified to reduce extensive streaming 
potential oscillations (*l-2 mV) caused by the relatively high recipient 
buffer flow rate used in this particular work (3.9 ml min-‘). This was 
accomplished by using two Ag/AgCl electrodes, rather than a single reference 
and stainless steel nipple, in a circuit arrangement analogous to that sugges- 
ted by van den Winkel et al. [27] . With this change, oscillations in baseline 
potentials were reduced to kO.2 mV. 
Potentiometric measurements were made with a Fischer Accumet pH 
Meter (Model 620) and were recorded on a Linear (Irvine, CA) Model 1201 
strip-chart recorder. The recorder output of the Fisher pH meter was also 
monitored by a computer-based data acquisition system. The data 
acquisition system consisted of a Keithley Model 179 TRMS-A Digital Multi- 
meter with IEEE-488 interface connected to a Commodore Pet Model 8032 
microcomputer. Appropriate software was used to detect and record auto- 
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matically the baseline, peak potentials and AE values (peak minus baseline 
potentials). 
Reagents 
All chemicals used were analytical-reagent grade. Standard solutions and 
buffers were prepared with reverse-osmosis deionized water. Buffer con- 
centrations refer to total ionic strength. Reagents were stored in sealed 
glass containers to minimize absorption of atmospheric ammonia. 
The sample stream diluent was 0.1 mol 1-l boric acid/sodium hydroxide, 
pH 9.50, containing 2 mmol 1-l EDTA. The recipient stream buffer at the 
detector was a 0.01 mol 1-l) HCl/Tris [ tris( hydroxymethyl)aminomethane] 
buffer, pH 7.50. 
Enzyme-reactor coils were stored refrigerated (4°C) between experiments 
and filled with a 0.1 mol 1-l phosphate storage buffer, pH 7.0, containing 
0.1% (w/w) EDTA and 0.05% (w/w) sodium azide. 
Weekly, a fresh 5 X 10eL mol 1-l creatinine stock solution (prepared in 
0.01 mol 1-l HCl) was diluted with deionized water to prepare working 
creatinine standards in the range of 25-5000 pmol 1-l (0.28-56.6 mg dl-‘). 
Procedures 
Evaluation of predialyzer unit. Initially, the predialysis unit and enzyme- 
reactor coil of Fig. 1 were removed so that the ammonia response could be 
calibrated and the ammonia content of serum and urine samples could be 
determined. Aqueous ammonium chloride standards (5 -5000 pmol 1-l) 
were sampled and corresponding AE values recorded. Following the stan- 
dards, ammonium chloride-spiked pooled serum (undiluted) and urine 
samples (1 + 99 diluted) were aspirated into the system and the resulting 
AE values were recorded. The predialysis unit was then reincorporated into 
the system and the same series of ammonium chloride standards and ammo- 
nium chloride-spiked serum and urine samples were analyzed. 
The pooled serum used for these experiments was obtained from healthy 
members of our research group. Reconstituted Fisher Level 1 Control 
Urine (lot 258-074) was used to prepare the ammonium chloride-spiked 
urine samples. These latter samples were prepared by diluting (with deion- 
ized water) 1 ml of reconstituted urine plus microliter amounts of 0.1 
mol 1-l ammonium chloride to a final volume of 100 ml. All serum and 
urine samples were stored frozen (-21°C) between experiments. 
Creatinine determinations. The complete flow configuration was used 
for creatinine determinations (Fig. 1). An initial series of aqueous creatinine 
standards ranging from 25 to 5000 pmol 1-i (0.28-56.6 mg dl-‘) were 
sampled. The potential was then allowed to return to baseline before serum 
or urine samples were analyzed. Following the serum and/or urine samples, 
the potential was again allowed to return to baseline before a second series 
of creatinine standards was sampled. Unknown creatinine levels were deter- 
mined from a linear least-squares fit of the combined initial and final 
aqueous calibration data in which peak-height potentials (AE) were plotted 
vs. the logarithm of creatinine concentrations. 
66 
RESULTS AND DISCUSSION 
The basic operating principles of the proposed creatinine system are 
straightforward. Samples are pumped from the autosampler, immediately 
air-segmented, and diluted with an alkaline buffer to convert partially 
ammonia in the sample to free ammonia gas. The samples then pass through 
the on-line gas predialyzer. The insert in Fig. 1 shows an expanded view of 
the predialysis unit and the chemical processes that take place within. As 
the sample passes through the predialyzer, free ammonia gas in the sample 
diffuses through the walls of the gas-permeable teflon tubing and is trapped 
as ammonium ions by the acid reservoir. Thus, as the sample traverses the 
length of the coiled tubing, the ammonia content of the sample is reduced 
while the creatinine level remains unchanged. Following the predialyzer, 
additional air-segmentation and buffer are added to the sample prior to its 
passage through the enzyme reactor. In the enzyme reactor, immobilized 
creatinine iminohydrolase catalyzes the following reaction: 
creatinine + Hz0 -f N-methylhydantoin + NH3 
Following the enzyme reactor, the sample stream is debubbled and passed 
through the flow-through potentiometric ammonia detector. The recorded 
potential changes (AE) are proportional to the logarithm of the creatinine 
concentration in the sample. 
In the design of the final automated arrangement, numerous studies were 
done to optimize sample ammonia removal and to maximize the response of 
the system to creatinine. The results of these studies are detailed below. 
Optimization of ammonia and creatinine response 
Initial experiments with the enzyme reactor coils demonstrated that 
approximately 50% conversion of creatinine to ammonia could be achieved 
with a sample-stream diluent pH of 9.50 and a total sample/diluent ratio of 
1:5. Consequently, the ammonia detection system was optimized under 
these conditions. For ammonia response studies, the gas predialyzer and the 
enzyme reactor were removed and the response was monitored as a function 
of varying flow rate combinations through the detector gas dialysis chamber. 
In all, 22 combinations of flow rates for the sample and recipient streams 
were examined. The flow-rate combination shown in Fig. 1 (3.9 ml min-’ 
recipient; 2.0 ml min-’ sample stream in the dialysis chamber) provided a 
good compromise for reasonably fast detector washout times and nearly 
optimal potential response for given ammonia concentrations. 
Typical calibration curves for aqueous ammonia and creatinine standards 
obtained by using this combination of flow rates are shown in Fig. 2. The 
creatinine curve was obtained by adding the enzyme reactor coil to the flow 
system while still leaving the predialyzer unattached. Response to creatinine 
paralleled that obtained for ammonia but was shifted to higher concen- 
trations owing to the incomplete conversion of creatinine to ammonia in the 
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Log [concentration (mot I-’ )] 
Fig. 2. Typical calibration curves obtained for ammonia (0) and aqueous creatinine stan- 
dards (+) with the system shown in Fig. 1 without gas predialyzer in place. Range (a) is 
the clinical range (50-1000 pmol 1.’ ,0.56-11 mg dl-‘). 
Fig. 3. Strip-chart recordings illustrating the effectiveness of the on-line gas predialyzer 
coil in removing endogenous ammonia at two different predialyzer temperatures: (A) 
without predialyzer in place; (B) with predialyzer maintained at 25°C; (C) with pre- 
dialyzer maintained at 45°C. Samples were aqueous ammonium chloride standards (a), 
ammonium chloride-spiked serum (b), and ammonium chloride-spiked (1 + 99) diluted 
urine (c). The range labeled (d) is the normal range of serum ammonia (10-100 pmol 1-l). 
Numbers above peaks in (A) refer to rmol 1-l ammonia in standards or added to serum 
and urine samples. 
reactor. Nevertheless, the creatinine response is nearly Nernstian (58 mV/ 
decade) in the range of 25-5000 gmol l-‘, a range which extends well below 
and above that required for clinical applications (50-1000 pmol 1-l). It 
should be noted that, given the ammonia detection capabilities of the 
proposed system, creatinine conversion efficiencies as low as 20% can be 
tolerated while still maintaining calibration linearity in the low end of the 
clinically important creatinine range. 
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Optimization of predialyzer efficiency 
Hydrochloric acid solutions (1.0 and 0.1 mol l-l), citric acid buffer 
(0.2 mol l-l, pH 3.2) and phosphoric acid buffer (0.2 mol l-l, pH 2.2) 
were each studied as potential solutions for the acid-trap reservoir. Though 
hydrochloric acid was used successfully in the previous predialyzer configur- 
ation [Ml, its use in the current system was not possible. At the elevated 
predialyzer temperatures used in these studies, hydrogen chloride readily 
diffused through the walls of the gas-permeable predialyzer coil and caused 
large changes in the sample stream pH. Of the two non-volatile buffers 
studied, the phosphoric acid buffer with lower pH (pH 2.2) proved to be 
the more efficient trapping medium because of the larger pH difference 
between the sample-stream buffer inside the coil and the external acidic 
reservoir. 
The most critical parameter with regard to the efficiency of on-line 
ammonia removal is the temperature of the predialysis unit. As shown in 
Fig. 3, for a given predialysis residence time, dramatic improvements in 
efficiency can be realized when the temperature of the unit is increased. 
Figure 3A shows a strip-chart recording obtained when aqueous ammonium 
chloride standards along with serum and urine samples spiked with varying 
levels of ammonium chloride were passed through the system without the 
predialyzer and enzyme reactor in place. Figure 3B and 3C show the res- 
ponse of the system toward the same standards and samples after the pre- 
dialyzer is added and thermostated at 25°C and 45”C, respectively. The 
baseline potential of the system also changes upon addition of the pre- 
dialyzer. This is a result of the removal of trace levels of ammonia in the 
diluent buffer. Taking this baseline shift into account, removal of ammonia 
is approximately 90% for all samples when the predialyzer is thermostated 
at 25°C. In contrast, elevating the predialysis temperature to 45°C results in 
efficiencies greater than 99X%, even for serum samples spiked to contain 
more than 1 mmol 1-l ammonia (10 times the highest levels normally found 
in serum). This dramatic temperature effect may be rationalized in terms of 
decreasing sample stream viscosity, increasing ammonia diffusion coefficient 
and decreasing ammonia solubility in the sample stream with increasing 
predialyzer temperature. 
Determinations of creatinine in physiological samples 
With the various components optimized, the performance of the com- 
plete continuous-flow arrangement was assessed. The response to creatinine 
in physiological samples (control serum and control urine) was studied with 
and without the predialyzer in place. Figure 4A shows the tracing obtained 
for a series of aqueous creatinine standards followed by serum and diluted 
urine (1 + 99) samples spiked with varying amounts of ammonium chloride. 
As can be seen, without removal of endogenous ammonia, the “creatinine” 
response closely follows the levels of ammonium chloride added. When the 
predialyzer is in place (Fig. 4B), regardless of the amount of ammonium 
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Fig. 5. Results from correlation study between the enzyme-baaed continuous-flow 
method and the Technicon SMAC calorimetric method. The SMAC assays were run at 
the Chemical Pathology Laboratory, University of Michigan Hospital. N = 30; slope = 
0.91 + 0.02; intercept = -0.20 f 0.07; correlation coefficient = 0.9966, standard error 
of estimate = kO.24 mg dl-I. 
the large number of selective enzymes which liberate ammonia, the system 
described here should offer a general approach for the selective deter- 
mination of a variety of biomolecules. Furthermore, it is likely that this con- 
cept could be extended to the removal of endogenous carbon dioxide from 
biological samples thereby enabling the adaptation of decarboxylating 
enzymes to the development of analogous bioanalytical systems. 
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